Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.1K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.1K
Protein Networks02:26

Protein Networks

4.2K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.4K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.7K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial.

Clinical and translational medicine·2021
Same author

[Effect of 4-week electroacupuncture intervention on "Browning" of white fat in rats and its mechanism].

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology·2021
Same author

A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.

Frontiers in genetics·2021
Same author

Successful treatment of two relapsed patients with t(11;19)(q23;p13) acute myeloid leukemia by CLAE chemotherapy sequential with allogeneic hematopoietic stem cell transplantation: Case reports.

Oncology letters·2021
Same author

Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways.

PLoS computational biology·2021
Same author

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib.

Leukemia·2021

Related Experiment Video

Updated: Oct 25, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K

A heterogeneous network embedding framework for predicting similarity-based drug-target interactions.

Qi An1, Liang Yu1

  • 1College of Computer Science and Technology at Xidian University, Xi'an 710071, P.R. China.

Briefings in Bioinformatics
|August 10, 2021
PubMed
Summary

This study introduces NEDTP, a novel framework for predicting drug-target interactions (DTIs) by integrating features from multiple networks. NEDTP enhances DTI prediction accuracy and offers solutions for negative sampling challenges.

Keywords:
drug-target interactionheterogeneous networkmachine learningnetwork embedding

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K

Related Experiment Videos

Last Updated: Oct 25, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Network science

Background:

  • Drug-target interactions (DTIs) are crucial for drug development.
  • Current DTI prediction methods often overlook multi-network features.
  • Integrating diverse biological data is essential for accurate DTI prediction.

Purpose of the Study:

  • To propose a novel Network EmbeDding framework in mulTiPlex networks (NEDTP) for DTI prediction.
  • To effectively extract and merge drug and target features from heterogeneous information networks.
  • To address limitations in existing DTI prediction methodologies.

Main Methods:

  • Constructed a similarity network using 15 heterogeneous information networks.
  • Employed random walks to extract node topology information and generate low-dimensional vectors.
  • Utilized a Gradient Boosting Decision Tree model for DTI classification.

Main Results:

  • NEDTP demonstrated superior accuracy in DTI prediction compared to state-of-the-art algorithms.
  • Validated new DTI predictions through multiple experimental perspectives.
  • Achieved significant improvements in predicting drug-target interactions.

Conclusions:

  • NEDTP offers an effective approach for DTI prediction by leveraging multi-network information.
  • The framework provides a robust solution for negative sampling in DTI prediction.
  • This study contributes novel insights and methods to the field of computational drug discovery.